Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples